Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2023 | Key stroke insights from the European Academy of Neurology conference

Diana Aguiar de Sousa, MD, PhD, University of Lisbon, Santa Maria Hospital, Lisbon, Portugal, recounts her highlights from the European Academy of Neurology (EAN) 2023 meeting led by experts in the field. EAN 2023 which provided a comprehensive overview of various topics, including bridging thrombolysis, updates on endovascular treatment, and discussions on brain-heart interactions. Emphasizing the significance of addressing stroke as the most prevalent neurological disease within a hospital setting, the meeting underlined the importance of staying informed about recent advancements in the field. This interview took place at the European Academy of Neurology (EAN) 2023 Congress in Budapest, Hungary.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.


Dr Aguiar de Sousa reported personal fees for AstraZeneca and Organon advisory board participation, travel support from Boehringer Ingelheim, DSMB participation for the SECRET trial (University of British Columbia), and speaking fees from Bayer and Bial.